Cargando…

COVID-19: Is herd immunity the only option for fragile Yemen?

The first case of COVID-19 in Yemen was confirmed on 10 April 2020. Having faced with a six-year long conflict that has destroyed half of its healthcare facilities and displaced millions, predictions of infections and mortality in Yemen suggested a looming healthcare catastrophe. Difficulty in imple...

Descripción completa

Detalles Bibliográficos
Autores principales: Noushad, Mohammed, Al-Saqqaf, Inas Shakeeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959686/
https://www.ncbi.nlm.nih.gov/pubmed/33737135
http://dx.doi.org/10.1016/j.ijid.2021.03.030
_version_ 1783665003158568960
author Noushad, Mohammed
Al-Saqqaf, Inas Shakeeb
author_facet Noushad, Mohammed
Al-Saqqaf, Inas Shakeeb
author_sort Noushad, Mohammed
collection PubMed
description The first case of COVID-19 in Yemen was confirmed on 10 April 2020. Having faced with a six-year long conflict that has destroyed half of its healthcare facilities and displaced millions, predictions of infections and mortality in Yemen suggested a looming healthcare catastrophe. Difficulty in implementing coordinated lockdowns and preventive measures due to the daily labor working nature of the majority of the population, provided the perfect breeding ground for the SARS-CoV-2 virus. However, official figures of infections and mortality are very low and there have not been confirmed reports of excess mortality. This could indicate that Yemen is silently marching towards forced herd immunity. Seroprevalence studies will provide useful insight into the COVID-19 transmission trajectory in Yemen, which can serve as a guide in planning vaccine distribution strategies and allocating the limited funds wisely.
format Online
Article
Text
id pubmed-7959686
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-79596862021-03-16 COVID-19: Is herd immunity the only option for fragile Yemen? Noushad, Mohammed Al-Saqqaf, Inas Shakeeb Int J Infect Dis Short Communication The first case of COVID-19 in Yemen was confirmed on 10 April 2020. Having faced with a six-year long conflict that has destroyed half of its healthcare facilities and displaced millions, predictions of infections and mortality in Yemen suggested a looming healthcare catastrophe. Difficulty in implementing coordinated lockdowns and preventive measures due to the daily labor working nature of the majority of the population, provided the perfect breeding ground for the SARS-CoV-2 virus. However, official figures of infections and mortality are very low and there have not been confirmed reports of excess mortality. This could indicate that Yemen is silently marching towards forced herd immunity. Seroprevalence studies will provide useful insight into the COVID-19 transmission trajectory in Yemen, which can serve as a guide in planning vaccine distribution strategies and allocating the limited funds wisely. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-05 2021-03-15 /pmc/articles/PMC7959686/ /pubmed/33737135 http://dx.doi.org/10.1016/j.ijid.2021.03.030 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Noushad, Mohammed
Al-Saqqaf, Inas Shakeeb
COVID-19: Is herd immunity the only option for fragile Yemen?
title COVID-19: Is herd immunity the only option for fragile Yemen?
title_full COVID-19: Is herd immunity the only option for fragile Yemen?
title_fullStr COVID-19: Is herd immunity the only option for fragile Yemen?
title_full_unstemmed COVID-19: Is herd immunity the only option for fragile Yemen?
title_short COVID-19: Is herd immunity the only option for fragile Yemen?
title_sort covid-19: is herd immunity the only option for fragile yemen?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959686/
https://www.ncbi.nlm.nih.gov/pubmed/33737135
http://dx.doi.org/10.1016/j.ijid.2021.03.030
work_keys_str_mv AT noushadmohammed covid19isherdimmunitytheonlyoptionforfragileyemen
AT alsaqqafinasshakeeb covid19isherdimmunitytheonlyoptionforfragileyemen